Drug therapy safety
Conditions
Interventions
Group 1: The decision aid provided by a study team member will be analysed descriptively via the phycisians’ written feedback. Additionally, the anticholinergic load of patients taking at least one a
Sponsors
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient admitted to the Geriatric Rehabilitation of the Agaplesion Bethanien Hospital in Heidelberg; Age = 65 years; Taking at least one strong anticholinergic drug on a regular basis (this condition does not affect the comparison group); cognitive and physical stable to participate in the study
Exclusion criteria
Exclusion criteria: Mental or physical condition which does not allow the study participation; Particularly, patients with stroke, postoperative delirium, or dementia are excluded; Missing informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development and testing of different models for predicting anticholinergic load (time point of analysis: study end); Examination of the practicability of the decision aid for reducing anticholinergic load via feedback questionnaires of the participating physicians (time point of examination: during study). | — |
Secondary
| Measure | Time frame |
|---|---|
| Characterization of patients with different anticholinergic loads by cognition tests as well as by the assessment of anticholinergic adverse drug reactions at admission and approximately 14 days later (time of examination: during study). | — |
Countries
Germany
Contacts
Public ContactTanja Mayer
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik
Outcome results
None listed